Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC). (October 2022)
- Record Type:
- Journal Article
- Title:
- Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC). (October 2022)
- Main Title:
- Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)
- Authors:
- Cho, B.C.
Lin, J.
Camidge, D.R.
Velcheti, V.
Solomon, B.
Lu, S.
Lee, K.H.
Kim, S.W.
Kao, S.
Diadziuskzko, R.
Beg, M.
Nagasaka, M.
Felip, E.
Besse, B.
Springfeld, C.
Popat, S.
Wolf, J.
Trone, D.
Stopatschinskaja, S.
Drilon, A. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 174(2022)Supplement 1
- Journal:
- European journal of cancer
- Issue:
- Volume 174(2022)Supplement 1
- Issue Display:
- Volume 174, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 174
- Issue:
- 1
- Issue Sort Value:
- 2022-0174-0001-0000
- Page Start:
- S1
- Page End:
- S2
- Publication Date:
- 2022-10
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(22)00812-7 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 24177.xml